C9136 HCPCS Level II code: Injection, factor viii, fc fusion protein, (recombinant), per i.u.
CMS terminated C9136: its last date of service was Mar 31, 2015. It stays here for looking up older claims; newer services need a current code.
Official description
C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.
Short description: Factor viii (eloctate)
HCPCS · United States
Medicare details
The indicators CMS publishes with C9136 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See Q9975
- Added
- Jan 1, 2015
- Terminated after
- Mar 31, 2015
Where C9136 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9136 still valid?
No. CMS terminated C9136; its last date of service was Mar 31, 2015. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9136?
CMS lists C9136’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9136
All C codesC9121Injection, argatroban, per 5 mgC9122Mometasone furoate sinus implant, 10 micrograms (sinuva)C9132Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activityC9133Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.C9134Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.C9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg